Jennifer Mills, PhD, MSW, MPH was named Vice President, Medical Affairs at Foundation Medicine in July 2022. She has two decades of experience building impactful partnerships across the nonprofit, industry and academic communities. In her current role, Jen leads the Medical Affairs team to enable and inform healthcare providers in their treatment decision-making, and to empower people impacted by cancer. She fosters innovative partnerships across the oncology community and helps drive her team’s efforts to make molecular profiling an indispensable tool for cancer care and research.

Jen joined Foundation Medicine in 2018 as Vice President, Patient and Professional Partnerships, where she built the company’s long-term engagement strategy with several critical segments of the oncology community. Her leadership resulted in deeper relationships with key oncology stakeholders, including societies, patient advocacy organizations, key institutions and individual influencers, and she also led development of several new, enduring engagement models.

Prior to joining Foundation Medicine in 2018, Jen spent eight years at Genentech leading various advocacy and alliance initiatives, including leading the U.S. effort to advance Genentech’s approach to patient engagement across the lifecycle and build novel patient-focused partnerships. She was also the co-founder of Genentech’s Advancing Inclusive Research effort.

Earlier in her career, Jen spent nearly a decade at the Lymphoma Research Foundation, where she oversaw nationwide programs and services for patients and caregivers. Jen’s oncology experience began in 1999 on the bone marrow and stem cell transplantation service at New York Presbyterian Hospital, where she provided direct patient care and created new programs to increase social connectedness through technology. She began her career in eastern Alabama with a focus on HIV/AIDS outreach and awareness efforts.

Jen received her PhD in social work from New York University, where she also served as an Adjunct Professor. Her dissertation research focused on the cycle of relapsed/refractory disease among young adults diagnosed with lymphoma. She holds a bachelor’s degree from Auburn University, a Masters of Social Work from Columbia University, and a Masters of Public Health from New York University, where she also completed a Post-Master’s Fellowship in End of Life and Palliative Care.